Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Cynosure has received market approval from the Korea Food & Drug Administration for its flagship Accolade workstation for the removal of pigmented lesions.
Subscribe to our email newsletter
Accolade is a high-powered 755nm, Q-switched Alexandrite laser for the removal of pigmented lesions. The unique combination of various spot sizes and the laser’s high repetition rates is said to allow for rapid treatment.
Introduced in the first quarter of 2008, the Accolade is the third Cynosure flagship product approved for marketing in South Korea, following the Elite Aesthetic Workstation for laser hair removal and the Cynergy Workstation with MultiPlex Technology for the treatment of dermatological vascular conditions. All three workstations are being distributed in South Korea through Seoul-based OrientMG.
Michael Davin, president and CEO of Cynosure, said: “Due to the prevalence of dermal melanoses among Asian populations, South Korea is a primary target market for Accolade. We also are pursuing regulatory approval in other Asia Pacific countries, including China.”